Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
570.75B | 573.50B | 552.24B | 483.42B | 404.86B | 453.47B | Gross Profit |
90.67B | 88.11B | 84.43B | 73.92B | 70.24B | 71.02B | EBIT |
15.16B | 15.67B | 15.62B | 12.65B | 11.50B | 10.40B | EBITDA |
28.45B | 29.02B | 26.78B | 21.88B | 20.18B | 19.53B | Net Income Common Stockholders |
10.35B | 10.11B | 8.56B | 8.51B | 7.85B | 6.75B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
61.34B | 54.96B | 51.68B | 47.17B | 49.78B | 42.55B | Total Assets |
324.45B | 324.61B | 307.56B | 285.30B | 256.49B | 243.45B | Total Debt |
49.28B | 67.90B | 69.97B | 59.55B | 58.51B | 58.87B | Net Debt |
-12.06B | 17.04B | 24.89B | 19.75B | 15.01B | 23.07B | Total Liabilities |
160.52B | 165.54B | 163.26B | 152.65B | 136.59B | 130.94B | Stockholders Equity |
155.61B | 151.00B | 137.07B | 125.46B | 113.63B | 106.63B |
Cash Flow | Free Cash Flow | ||||
0.00 | 15.38B | 5.01B | 8.10B | 12.08B | 1.24B | Operating Cash Flow |
0.00 | 25.04B | 13.65B | 18.36B | 21.26B | 14.41B | Investing Cash Flow |
0.00 | -11.66B | -9.72B | -17.84B | -10.84B | -12.91B | Financing Cash Flow |
0.00 | -6.50B | -1.87B | -4.53B | -3.33B | 891.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥61.20B | 6.13 | 3.15% | -0.14% | 24.53% | ||
79 Outperform | $11.07T | 12.02 | 10.17% | 3.48% | -4.85% | 2.91% | |
79 Outperform | $8.34T | 9.53 | 11.74% | 3.32% | 10.04% | -13.12% | |
77 Outperform | $4.67T | 9.21 | 13.98% | 3.31% | 7.44% | 8.27% | |
73 Outperform | ¥166.08B | 8.88 | 3.90% | 10.79% | 1.30% | ||
72 Outperform | $10.96T | 12.37 | 15.55% | 2.60% | 4.95% | 11.34% | |
56 Neutral | $7.25B | 3.36 | -3.66% | 5.65% | 0.66% | -50.71% |